Bioeel
9 articole · RSS
Pharmaceutical Distributor Bioeel Has RON20M Investment Budget In 2025
Pharmaceutical company Bioeel, which specializes in the distribution of medicines and is one of the top 10 players in the market, has a budget of RON20 million for investments this year, which will go towards warehousing space, vehicles, and equipment.
Bioeel’s Pharmaceutical Distribution Business Overshoots RON1B Revenue Mark In 2024
Pharmaceutical company Bioeel posted RON1.2 billion revenue from its pharmaceutical distribution business in Romania in 2024, an increase of about 37% year-on-year, Finance Ministry data sho...
Pharma Group Bioeel 1Q/2023 Turnover Rises 40% To over RON215M
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first quarter of this year raked in turnover of above RON215 million (aro...
Pharma Group Bioeel Expects RON710M Turnover in 2023, Up 3.5% YOY
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, projects total turnover worth around RON710.6 million in 2023 (around EUR144 mil...
Pharma Group Bioeel Ends 2022 with RON686M Turnover, Up 22% YOY
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2022 generated turnover worth around RON686.4 million (EUR139.5 million) at g...
Pharma Group Bioeel Expects RON630M Turnover in 2022
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, estimates it will generate turnover of around RON630 million (EUR127.5 million)...
Pharma Group Bioeel Sees 1H/2022 Turnover Rise by 21% To over RON312M
Pharma group Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first half of this year generated turnover worth RON312 mill...
Pharma Group Bioeel Bets on 7-8% Turnover Growth in 2022
Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, expects 7-8% turnover growth at group level for 2022 on the year.
Pharma Group Bioeel Hits RON562M Turnover in 2021, Up 18% YOY
Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2021 generated turnover worth RON562 million (EUR114.2 million...